Login / Signup

Isoliquiritigenin Decreases Bone Resorption and Osteoclast Differentiation.

Kaitlyn M JoyceCarmen P WongIan A ScrivenDawn A OlsonDaniel R DoergeAdam J BranscumLara H SattgastWilliam G HelferichRussell T TurnerUrszula T Iwaniec
Published in: Molecular nutrition & food research (2022)
In conclusion, dietary ILQ reduces bone resorption in vivo and osteoclast differentiation in vitro, by mechanisms likely differing from actions of ovarian hormones.
Keyphrases
  • bone loss